Evidence map›Paper›PMID 35765690›Full record

ArticleMayo Clinic proceedings. Innovations, quality & outcomes2022

Impact of Severe Acute Respiratory Syndrome Coronavirus 2-Induced COVID-19 on Fixed Operating Room Times in Urologic Operations.

Laura E Geldmaker, Christopher H Hasse, Bryce A Baird, Daniela A Haehn, Abena N Anyane-Yeboah, Mikolaj A Wieczorek, Colleen T Ball, Chandler D Dora, Timothy D Lyon, David D Thiel

Open access · goldAbstract read
In one paragraph

Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Laura E GeldmakerDepartment of Urology, Mayo Clinic, Jacksonville, FL.
Christopher H HasseDepartment of Administration, Mayo Clinic, Jacksonville, FL.
Bryce A BairdDepartment of Urology, Mayo Clinic, Jacksonville, FL.
Daniela A HaehnDepartment of Urology, Mayo Clinic, Jacksonville, FL.
Abena N Anyane-YeboahDepartment of Administration, Mayo Clinic, Jacksonville, FL.
Mikolaj A WieczorekDepartment of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, FL.
Colleen T BallDepartment of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, FL.
Chandler D DoraDepartment of Urology, Mayo Clinic, Jacksonville, FL.
Timothy D LyonDepartment of Urology, Mayo Clinic, Jacksonville, FL.
David D ThielDepartment of Urology, Mayo Clinic, Jacksonville, FL.
Mayo Clinic in Florida · USWinnMed · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the impact of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, on operating room (OR) efficiency for urologic procedures using the concept of fixed OR times. Patients and Methods: Over a 24-month period, urology OR data were prospectively collected. Operations were divided into fixed and variable time points. The fixed OR times were in-roomw to anesthesia-release time, anesthesia-release to cut time, in-room to cut time, and close to wheels-out time. Data from January 1, 2019, to December 31, 2019, were pre-COVID-19 data, and data from April 1, 2020, to December 31, 2020, were post-COVID-19 data. Operations were grouped into endoscopic, implant, major open, and robotic-assisted cases. In the post-COVID-19 era, all patients had a negative polymerase chain reaction test result within 48 hours of operation. The Wilcoxon rank sum test was used to compare the fixed OR times between the pre- and post-COVID-19 eras. Results: A total of 3189 procedures were evaluated: 2058 endoscopic operations (1124 in the pre-COVID-19 era and 934 in the post-COVID-19 era), 343 implant procedures (192 in the pre-COVID-19 era and 151 in the post-COVID-19 era), 222 major open procedures (119 in the pre-COVID-19 era and 103 in the post-COVID-19 era), and 566 robotic-assisted procedures (338 in the pre-COVID-19 era and 228 in the post-COVID-19 era). There were no fixed OR times in any of the examined groups that were negatively impacted by COVID-19. The percentage of the total OR time occupied by fixed OR variables in the pre-COVID-19 era was 40.6% for endoscopic operations, 41.1% for implant procedures, 29.8% for major open procedures, and 21.8% for robotic-assisted procedures. Conclusion: A substantial portion of the total OR time includes fixed time points. Furthermore, COVID-19 did not have a negative impact on fixed OR times in a negative testing environment. Urologic OR efficiency should be maintained in the post-COVID-19 era.

Indexed as

AGS, artificial genitourinary sphincterARCT, anesthesia-release to cut timeCI, confidence intervalCOVID-19, coronavirus disease 2019CTWO, close to wheels-out timeIQR, interquartile rangeIRAT, in-room to anesthesia-release timeIRCT, in-room to cut timeOR, operating roomSARS-CoV-2, severe acute respiratory syndrome coronavirus 2

Identifiers

PMID35765690
PMCPMC9222149
OpenAlexW4283324814

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.